Effect of Telitacicept on Antibody Titers in Primary APS Patients

Conditions: Antiphospholipid Syndrome (APS) Interventions: Drug: Telitacicept; Drug: SOC Sponsors: Ruijin Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials